Biotech

All Articles

Basilea scores $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work establishing brand new antifungals has actually obtained a notable imp...

Capricor sells Europe rights to late-stage DMD treatment for $35M

.Having presently scooped up the USA civil liberties to Capricor Therapeutics' late-stage Duchenne m...

FDA fragments adcomm for Applied's rare condition medication

.After pushing the choice meeting for Applied Therapeutics' metabolic disorder drug govorestat, the ...

Novo inks $600M NanoVation package to examine genetic medications ex-liver

.Novo Nordisk is continuing its own push in to hereditary medications, accepting pay NanoVation Ther...

Innovent web links cytokine to intestines cancer actions

.Innovent Biologics has actually made the instance that its own gate inhibitor-cytokine blend protei...

Merck, Daiichi ADC hits target in stage 3 lung cancer research study

.A period 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina grows artificial intelligence focus with collab to pick cancer cells targets

.Five months after Rakovina Rehabs pivoted towards artificial intelligence, the cancer-focused biote...

Ascendis' dwarfism drug smash hits in phase 3, threatens BioMarin

.Ascendis Pharma has emerged as a potential danger to BioMarin's Voxzogo, reporting stage 3 growth d...

Despite ph. 3 overlook, Alkeus observes path ahead of time for eye disease asset

.Though Alkeus Pharmaceuticals' oral eye disease resource neglected to dramatically lessen geographi...

Kairos goes public along with $6M IPO to cash trials of cancer medicine

.With a trio of biotechs reaching the Nasdaq on Friday, it was actually very easy to overlook a smal...